… In this editorial, we review the clinical observations related to diabetes and COVID-19 in …
We then outline proposed mechanisms that may predispose individuals with diabetes both to …

… on the severity of COVID-19 has not been … others diabetes drugs on COVID-19 patients. As
such, no available evidence has yet suggested that glucose-lowering drugs – including those …

… the risk of mortality for COVID-19. Regarding T2DM, four risk factors for diabetic patients
with COVID-19, compared to COVID patients without diabetes were proposed, which can …

… of infection in type 1 versus type 2 diabetic patients. In summary, it is apparent that persons
with diabetes are at increased risk for COVID-19 infection, and are at increased risk for …

… obese and type 2 diabetic patients, not only during the current COVID-19 crisis, but to … in
health outcomes in patients infected with COVID-19. The current COVID-19 pandemic resulting …

… indicated that diabetes patients were of greater risk of mortality as a result of Covid-19 [8].
Consequently, there has been an upsurge of information relating to diabetes and Covid-19. …

… in their commentary “COVID-19 in Patients with Diabetes”, that for patients with COVID-19
infections, the presence of diabetes … of glycemic control during COVID-19 infections because …

… summary of diabetes management as well as the particular considerations to care people
living with diabetes during COVID-19 pandemic. … This review produced a summary of diabetes …

… COVID-19 death in T2DM patients with COVID-19, which highlights the potential of these new
drugs used to prevent COVID-19 death in T2DM patients with COVID-19. … risk of COVID-19 …

… Should we supplement patients with vitamin D? We examine the biological plausibility and
evidence for a role of vitamin D in COVID-19 patients, and provide a framework for guidance …